- Home
- CORT vs MASI Comparison
CORT vs MASI Comparison
Compare CORT & MASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- MASI
- Stock Information
- Founded
- CORT 1998
- MASI 1989
- Country
- CORT United States
- MASI United States
- Employees
- CORT N/A
- MASI N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- MASI Medical/Dental Instruments
- Sector
- CORT Health Care
- MASI Health Care
- Exchange
- CORT Nasdaq
- MASI Nasdaq
- Market Cap
- CORT 7.5B
- MASI 8.2B
- IPO Year
- CORT N/A
- MASI 2007
- Fundamental
- Price
- CORT $69.42
- MASI $164.71
- Analyst Decision
- CORT Strong Buy
- MASI Buy
- Analyst Count
- CORT 4
- MASI 6
- Target Price
- CORT $142.00
- MASI $187.00
- AVG Volume (30 Days)
- CORT 1.6M
- MASI 579.3K
- Earning Date
- CORT 07-28-2025
- MASI 08-05-2025
- Dividend Yield
- CORT N/A
- MASI N/A
- EPS Growth
- CORT 8.36
- MASI N/A
- EPS
- CORT 1.14
- MASI N/A
- Revenue
- CORT $685,446,000.00
- MASI $2,126,800,000.00
- Revenue This Year
- CORT $35.83
- MASI N/A
- Revenue Next Year
- CORT $35.24
- MASI $7.74
- P/E Ratio
- CORT $59.62
- MASI N/A
- Revenue Growth
- CORT 30.93
- MASI 16.68
- 52 Week Low
- CORT $29.42
- MASI $101.61
- 52 Week High
- CORT $117.33
- MASI $194.88
- Technical
- Relative Strength Index (RSI)
- CORT 44.85
- MASI 49.72
- Support Level
- CORT $66.49
- MASI $161.18
- Resistance Level
- CORT $72.72
- MASI $172.55
- Average True Range (ATR)
- CORT 2.79
- MASI 4.93
- MACD
- CORT -0.49
- MASI -0.71
- Stochastic Oscillator
- CORT 26.81
- MASI 39.58
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
About MASI Masimo Corporation
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.